Abbott Receives FDA Approval for Healon EndoCoat OVD for Cataract Surgery

Abbott Receives FDA Approval for Healon EndoCoat OVD for Cataract Surgery

Abbott announced that it has expanded its Healon® family of ophthalmic viscosurgical devices (OVDs) with the U.S. Food and Drug Administration approval of Healon EndoCoat OVD, a device intended for use as a surgical aid in cataract extraction and intraocular lens (IOL) implantation.

This clear, viscous formula is injected into a patient’s eye to protect and coat the eye during surgery, reducing trauma to the inside layer of the cornea and other surrounding tissues.

The surgical delivery system for Healon EndoCoat OVD includes a number of features for increased patient safety and ease of handling for the physician, including a smaller delivery device and improved ergonomics for a smooth and consistent delivery of the formula into the eye.

Healon EndoCoat OVD can be used in combination with any other Healon products such as Healon, Healon GV or Healon5.

EXPLORE